DMRT3 and cerebral palsy: The second report identified the DMRT3 enhancer as a candidate involved in the pathogenesis of spastic cerebral palsy (Kubota et al., 2018), a disease that affects the movement and posture and is caused by a genetic abnormality in 30% of cerebral palsy cases (Fahey et al., 2017).